Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 689

1.

Indication of the extent of hepatectomy for hepatocellular carcinoma on cirrhosis by a simple algorithm based on preoperative variables.

Cescon M, Cucchetti A, Grazi GL, Ferrero A, ViganĂ² L, Ercolani G, Zanello M, Ravaioli M, Capussotti L, Pinna AD.

Arch Surg. 2009 Jan;144(1):57-63; discussion 63. doi: 10.1001/archsurg.2008.522.

PMID:
19153326
2.

Recovery from liver failure after hepatectomy for hepatocellular carcinoma in cirrhosis: meaning of the model for end-stage liver disease.

Cucchetti A, Ercolani G, Cescon M, Ravaioli M, Zanello M, Del Gaudio M, Lauro A, Vivarelli M, Grazi GL, Pinna AD.

J Am Coll Surg. 2006 Nov;203(5):670-6. Epub 2006 Aug 17.

PMID:
17084328
3.

Model for End-stage Liver Disease score fails to predict perioperative outcome after hepatic resection for hepatocellular carcinoma in patients without cirrhosis.

Teh SH, Sheppard BC, Schwartz J, Orloff SL.

Am J Surg. 2008 May;195(5):697-701. doi: 10.1016/j.amjsurg.2007.05.054.

PMID:
18367132
4.

Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis.

Fan ST, Lai EC, Lo CM, Ng IO, Wong J.

Arch Surg. 1995 Feb;130(2):198-203.

PMID:
7848092
5.

Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis.

Cucchetti A, Ercolani G, Vivarelli M, Cescon M, Ravaioli M, La Barba G, Zanello M, Grazi GL, Pinna AD.

Liver Transpl. 2006 Jun;12(6):966-71.

6.

Role of hepatitis B virus infection in the prognosis after hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a Western dual-center experience.

Cescon M, Cucchetti A, Grazi GL, Ferrero A, ViganĂ² L, Ercolani G, Ravaioli M, Zanello M, Andreone P, Capussotti L, Pinna AD.

Arch Surg. 2009 Oct;144(10):906-13. doi: 10.1001/archsurg.2009.99.

PMID:
19841357
7.

Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.

Yi NJ, Suh KS, Lee HW, Shin WY, Kim J, Kim W, Kim YJ, Yoon JH, Lee HS, Lee KU.

Liver Transpl. 2009 May;15(5):496-503. doi: 10.1002/lt.21606.

8.

Is portal hypertension a contraindication to hepatic resection?

Cucchetti A, Ercolani G, Vivarelli M, Cescon M, Ravaioli M, Ramacciato G, Grazi GL, Pinna AD.

Ann Surg. 2009 Dec;250(6):922-8. doi: 10.1097/SLA.0b013e3181b977a5.

PMID:
19855258
9.

A thoracoabdominal hepatectomy and a transdiaphragmatic hepatectomy for patients with cirrhosis and hepatocellular carcinoma.

Takenaka K, Fujiwara Y, Gion T, Maeda T, Shirabe K, Shimada M, Yanaga K, Sugimachi K.

Arch Surg. 1998 Jan;133(1):80-3.

PMID:
9438764
10.

No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach.

Torzilli G, Makuuchi M, Inoue K, Takayama T, Sakamoto Y, Sugawara Y, Kubota K, Zucchi A.

Arch Surg. 1999 Sep;134(9):984-92.

PMID:
10487594
11.

Hepatic resection for hepatocellular carcinoma in severely cirrhotic livers.

Kaibori M, Matsui Y, Kitade H, Kwon AH, Kamiyama Y.

Hepatogastroenterology. 2003 Mar-Apr;50(50):491-6.

PMID:
12749254
12.
13.
14.

Postoperative complications of hepatectomy for hepatocellular carcinoma in relation to liver fibrosis.

Nakayama H, Takayama T, Hemmi A.

Hepatogastroenterology. 2005 Mar-Apr;52(62):587-90.

PMID:
15816483
16.

Limits and benefits of exclusive transthoracic hepatectomy approach for patients with hepatocellular carcinoma.

Pocard M, Sauvanet A, Regimbeau JM, Duwat O, Farges O, Belghiti J.

Hepatogastroenterology. 2002 Jan-Feb;49(43):32-5.

PMID:
11941979
17.

The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: a prospective survey.

Huo TI, Lin HC, Hsia CY, Huang YH, Wu JC, Chiang JH, Chiou YY, Lui WY, Lee PC, Lee SD.

Dig Liver Dis. 2008 Nov;40(11):882-9. doi: 10.1016/j.dld.2008.01.015. Epub 2008 Mar 12.

PMID:
18339595
18.

Clarification of risk factors for hepatectomy in patients with hepatocellular carcinoma.

Ishikawa M, Yogita S, Miyake H, Fukuda Y, Harada M, Wada D, Tashiro S.

Hepatogastroenterology. 2002 Nov-Dec;49(48):1625-31.

PMID:
12397750
19.
20.

The safety of intra-abdominal surgery in patients with cirrhosis: model for end-stage liver disease score is superior to Child-Turcotte-Pugh classification in predicting outcome.

Befeler AS, Palmer DE, Hoffman M, Longo W, Solomon H, Di Bisceglie AM.

Arch Surg. 2005 Jul;140(7):650-4; discussion 655.

PMID:
16027329

Supplemental Content

Support Center